2012
DOI: 10.1016/j.cellimm.2011.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
60
1
5

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(69 citation statements)
references
References 27 publications
3
60
1
5
Order By: Relevance
“…To evaluate the effect of TREM-1 signaling on the outcome of S. suis infection, we used the recombinant extracellular domain of TREM-1 as an inhibitor and use the agonistic TREM-1 antibody as an activator of signaling, as described previously (33,34,39). PBS and isotype antibody were used as negative controls, respectively.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…To evaluate the effect of TREM-1 signaling on the outcome of S. suis infection, we used the recombinant extracellular domain of TREM-1 as an inhibitor and use the agonistic TREM-1 antibody as an activator of signaling, as described previously (33,34,39). PBS and isotype antibody were used as negative controls, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…It can be induced at high levels on neutrophils and monocytes and further amplifies Toll-like receptor (TLR)-initiated responses against microbial challenges, potentiating the secretion of proinflammatory cytokines and chemokines with the help of the DAP12 adaptor protein in response to bacterial and fungal infections (30)(31)(32). Blockage of TREM-1 signaling could protect mice against lipopolysaccharide (LPS)-induced shock and microbial sepsis caused by live Escherichia coli and Pseu-domonas aeruginosa, as well as cecal ligation and puncture (30,33,34). Therefore, TREM-1 has been recognized as an essential regulator of innate immunity in sepsis syndrome and as a potential therapeutic target for septic shock (35).…”
mentioning
confidence: 99%
“…While, high levels of sTREM-1 have been found in patients with severe forms of allergic asthma (Bucova et al, 2012), it has been suggested that sTREM-1 may have an antiinflammatory role, by acting through a mechanism whereby sTREM blocks interactions of membrane-bound TREM-1 with its natural ligand in a way similar to the recognized interaction between the soluble form of the TNF-α receptor and membrane TNF-α receptor (Gibot and Massin, 2006; Science Publications -Bourboulis et al, 2008). Furthermore, it has been suggested that sTREM could be used as therapeutic for inflammatory conditions such as rheumatoid arthritis and sepsis (Kim et al, 2012;Wang et al, 2012). The cytokine array used in this study measures both membrane and soluble forms of TREM-1, therefore, further analysis of the effect of Moringa on this cytokine is needed.…”
Section: Discussionmentioning
confidence: 99%
“…In general the outcome depends on whether TREM-1 is neutralized or the gene deleted. Neutralization of TREM-1 attenuates inflammation, preventing experimentally induced bacterial septic shock [36][37][38][39][40][41][42] and attenuating disease severity in mice infected with Leishmania major, influenza virus and Legionella pneumophila. 43 However, the situation for Klebsiella pneumoniae appears to be different with TREM-1/3-deficient mice showing impaired host defence, 44 similar to that observed for pneumococcal pneumonia 45 and Pseudomonas aeruginosa 8 in the same mice.…”
Section: Articlesmentioning
confidence: 99%